Fondazione Telethon
Non-Profit & Charitable Organizations · Italy · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Via Poerio 14, Milano, Lombardy, 20129, ...Phone Number
+39 6440151Website
www.fondazionetelethon.itRevenue
$19.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Fondazione Telethon
Fondazione Telethon is dedicated to funding research aimed at finding cures for rare genetic diseases. Since its inception in 1990, it has supported numerous researchers and projects, focusing on the diagnosis and treatment of these conditions. The foundation engages with private donors and companies to raise funds, emphasizing the importance of collaboration in providing hope to affected families. Their mission is to ensure that every child born with a rare genetic disease has the opportunity to grow and thrive.Explore more
Popular SearchesFondazione TelethonTelethonTelethon Milano NordSIC Code 83,839NAICS Code 81,813Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fondazione Telethon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Fondazione Telethon recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Fondazione Telethon launches new products
Funding: Get notified immidiatlly once Fondazione Telethon has new funding data
Check if Fondazione Telethon has recently received funding, and reach out quickly before it becomes old news!
Check out if Fondazione Telethon is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Fondazione Telethon
Click to see if Fondazione Telethon had a recent Job posting/layoffs
Fondazione Telethon, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Fondazione Telethon is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Fondazione Telethon is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Fondazione Telethon.
Fondazione Telethon Tech Stack
A closer look at the technologies used by Fondazione Telethon
Fondazione Telethon News & Media
Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)
ROME, Nov. 14, 2025 /PRNewswire/ -- Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), recommending marketing authorisation in the European Union for Waskyra™, an ex vivo gene...Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization (CDMO) expertise in High Quality (HQ) plasmid DNA production, and Good Manufacturing Practice- (GMP) compliant plasmid DNA batches to manufacture HQ plasmid DNA forCan-Fite Enters Rare Genetic Disease Field Based on impactful findings of a Fondazione Telethon and Naples University Researcher showing Piclidenoson is efficacious in Treating Lowe Syndrome
PETACH TIKVA, Israel--(BUSINESS WIRE)---- $CANF--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today it plans to develop its lead drug candidate, Piclidenoson, for the treatment of Lowe Syndrome based on recent efficacy findings by Dr. Antonella De Matteis, Professor of Biology, Department of Molecular Medicine and Medical Biotechnology atSofinnova Partners Announces Third Investment From Its Italian Fund
MILAN--(BUSINESS WIRE)-- #investing--Sofinnova Partners announces its third investment from its Italian Fund, bringing the total financing by Sofinnova to €25 million in six months.
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Fondazione Telethon
Sign Up For FreeTo access detailed company insights
Fondazione Telethon is dedicated to funding research aimed at finding cures for rare genetic diseases. Since its inception in 1990, it has supported numerous researchers and projects, focusing on the diagnosis and treatment of these conditions. The foundation engages with private donors and companies to raise funds, emphasizing the importance of co... Read More
